Trials / Unknown
UnknownNCT05823935
Laparoscopic Versus Vaginal Cuff Closure During LH in Benign Gynecological Lesions
Laparoscopic Versus Vaginal Cuff Closure During Laparoscopic Hysterectomy in Benign Gynecological Lesions
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- Female
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To compare vaginal cuff closure via Bakay purse string with vaginal cuff closure via vaginal route with continuous locked suturing after total laparoscopic hysterectomy for benign lesions.
Detailed description
The objective of the present study is to compare 2 different methods for vaginal cuff closure after total laparoscopic hysterectomy for benign lesions regarding operative time, vaginal length, vaginal cuff dehiscene, hematoma formation. The first method is the Bakay purse string and the second is the closure of the vault via vaginal route with continuous locked suturing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Bakay purse string | After developing the bladder flap, Vicryl polyglactin 910 sutures (Ethicon, Inc, Somerville, NJ) will be placed on the line between the cervicovaginal junction and the bladder starting at either 4 to 3 o'clock or 8 to 9 o'clock, as anchor sutures. Paying attention not to get closer than 1 cm to the bladder, the first suture will be passed from 4 o'clock to 3 o'clock and continued circumferentially in a full-thickness purse string fashion through 3, 1, 10, 8, 7, 5 o'clock completing a circle while including both uterosacral ligaments. |
| PROCEDURE | Cuff closure via vaginal route group | After the uterus will be removed via vaginal route, vaginal cuff ends will be grasped via vaginal approach and sutured continuous locked sutures using Vicryl polyglactin 910 sutures in one layer. |
Timeline
- Start date
- 2022-11-05
- Primary completion
- 2023-11-01
- Completion
- 2023-11-01
- First posted
- 2023-04-21
- Last updated
- 2023-04-21
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05823935. Inclusion in this directory is not an endorsement.